Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.24.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Mar. 31, 2023
Current assets    
Cash and cash equivalents $ 48,959 $ 75,058
Restricted cash 506 500
Accounts receivable, net 217,239 178,189
Prepaid expenses and other current assets 20,586 12,319
Total current assets 287,290 266,066
Property and equipment, net 43,598 39,327
Right-of-use assets 9,594 10,073
Intangible assets, net 330,531 379,632
Goodwill 411,055 561,576
Other non-current assets 24,567 9,882
TOTAL ASSETS 1,106,635 1,266,556
Current liabilities    
Accounts payable 159,525 119,338
Accrued revenue share 66,161 69,221
Accrued compensation 7,523 10,984
Other current liabilities 35,447 21,377
Total current liabilities 268,656 220,920
Long-term debt, net of debt issuance costs 374,034 410,522
Deferred tax liabilities, net 4,664 13,940
Other non-current liabilities 13,583 13,919
Total liabilities 660,937 659,301
Commitments and contingencies
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 850,989 822,217
Treasury stock (758,125 shares at December 31, 2023, and March 31, 2023) (71) (71)
Accumulated other comprehensive loss (46,493) (41,945)
Accumulated deficit (358,837) (175,115)
Total stockholders’ equity 445,698 605,196
Non-controlling interest 0 2,059
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 1,106,635 $ 1,266,556